| 000 | 01831 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516153220.0 | ||
| 264 | 0 | _c20140102 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a2042-8189 | ||
| 024 | 7 |
_a10.4997/JRCPE.2013.203 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHassan, S A | |
| 245 | 0 | 0 |
_aHospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards. _h[electronic resource] |
| 260 |
_bThe journal of the Royal College of Physicians of Edinburgh _c2013 |
||
| 300 |
_a103-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAbdominal Pain _xchemically induced |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aBacterial Proteins _xanalysis |
| 650 | 0 | 4 |
_aBacterial Toxins _xanalysis |
| 650 | 0 | 4 | _aClostridioides difficile |
| 650 | 0 | 4 |
_aClostridium Infections _xchemically induced |
| 650 | 0 | 4 |
_aCross Infection _xepidemiology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 |
_aEnterotoxins _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetronidazole _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProton Pump Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aSepsis _xcomplications |
| 700 | 1 | _aRahman, R A | |
| 700 | 1 | _aHuda, N | |
| 700 | 1 | _aWan Bebakar, W M | |
| 700 | 1 | _aLee, Y Y | |
| 773 | 0 |
_tThe journal of the Royal College of Physicians of Edinburgh _gvol. 43 _gno. 2 _gp. 103-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4997/JRCPE.2013.203 _zAvailable from publisher's website |
| 999 |
_c22805995 _d22805995 |
||